OMERS Administration Corp’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

OMERS Administration Corp’s Portfolio BIOT Stock Details BIOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-247,005	Closed	-$2.49M	–	373
2022 Q4	$2.49M	Hold	247,005	–	–	0.04%	87
2022 Q3	$2.45M	Hold	247,005	–	–	0.04%	90
2022 Q2	$2.44M	Hold	247,005	–	–	0.04%	97
2022 Q1	$2.43M	Buy	247,005 +190,377	+336%	+$1.87M	0.03%	101
2021 Q4	$557K	Buy	+56,628	New	+$556K	0.01%	129

OMERS Administration Corp's BIOT Position: Q1 2023 in Review

OMERS Administration Corp sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q1 2023, closing a stake of 247,005 shares — an estimated $2.49M sold.

OMERS Administration Corp first reported a position in BIOT in Q4 2021 and held it in 5 quarters. The position peaked at $2.49M in Q4 2022. 0 funds tracked by Wall St. Rank hold BIOT as of Q1 2023.

OMERS Administration Corp reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
OMERS Administration Corp sold 247,005 Biotech Acquisition Company Class A Ordinary Shares shares in Q1 2023, an estimated $2.49M.
OMERS Administration Corp first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q4 2021 and held it in 5 quarters.
OMERS Administration Corp's Biotech Acquisition Company Class A Ordinary Shares position peaked at $2.49M in Q4 2022.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q1 2023.

Based on OMERS Administration Corp's 13F filing for Q1 2023, filed 12 May 2023.